SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-010383
Filing Date
2023-03-31
Accepted
2023-03-31 17:01:08
Documents
51
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1547492
2 ex23-1.htm EX-23.1 3560
3 ex31-1.htm EX-31.1 11945
4 ex31-2.htm EX-31.2 10664
5 ex32-1.htm EX-32.1 4429
6 ex32-2.htm EX-32.2 4235
  Complete submission text file 0001493152-23-010383.txt   4370369

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inti-20221231.xsd EX-101.SCH 22011
8 XBRL CALCULATION FILE inti-20221231_cal.xml EX-101.CAL 40586
9 XBRL DEFINITION FILE inti-20221231_def.xml EX-101.DEF 113404
10 XBRL LABEL FILE inti-20221231_lab.xml EX-101.LAB 223988
11 XBRL PRESENTATION FILE inti-20221231_pre.xml EX-101.PRE 180620
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 444515
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 23788938
SIC: 2834 Pharmaceutical Preparations